“The present condition has uncovered some structural weaknesses during the EU’s medicines supply chain and a substantial dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides claimed. She suggested that supply chain concerns be resolved within an EU pharmac… Read More